C71T
CANCELLED SECTION 71
01/16/2026
Back to search
Official data from USPTO
CYTOTUNE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CYTOTUNE
ST13
US500000079242493Class
1, 5, 42
Filing
79242493
Registration
5790755
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
02/10/2026
Trademark type
Word
Nice classes
1, 5, 42
Filing date
08/08/2018
Registration date
07/02/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/16/2026
Last transaction
02/10/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Ibaraki, JP
Examiner
BUTTON, JENNIFER JO
Law office
L50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ID Pharma Co., Ltd.
Representatives
Stacey R. Halpern KNOBBE MARTENS OLSON & BEAR LLP
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Protein in raw material form for scientific and medical research; enzymes for scientific and medical research; biochemicalspolypeptides for in vitro and in vivo scientific and research use; chemical reagents comprising antibodies not for medical or veterinary purposes; chemical agents for chelating and sequestering; higher fatty acids for use in the field of scientific researchreagentscosmeticspharmaceuticals
Class 5
Anti-cancer preparations; anti-sarcoma preparations; contrasting agent for X-ray imaging; diagnostic reagents for medical purposes; radio-isotope markers for therapeutic or diagnostic use; veterinary preparations for veterinary vaccines; biological preparations for the treatment of cancercritical limb ischemiacystic fibrosisretinitis pigmentosaAIDSinfluenzaAlzheimer's disease; preparations for gene therapyintroducing genes to human and animal cellstissuesorgans and living bodiesgrowth media for medical purposes; vaccines; gene vaccines; vectors for introducing genes to human and animal cellstissuesorgans and living bodiesgrowth media for medical usefor gene therapy
Class 42
Testinginspectionresearchdevelopment of pharmaceuticalscosmeticsfoodstuff; testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy; testinginspectionresearchdevelopment of vaccines; testinginspectionresearchdevelopment of recombinant proteins; medicalchemicalbiochemicalbiological and bacteriological research and functional analysis of genes or proteins; testinginspectionresearch related to technologies for manufacturing genetically engineered animalsplantsvectors; testinginspectionresearchdevelopment of vector technologiesmedical and scientific research in the field of genetics and genetic engineering; testinginspectionresearch on agriculturelivestock breedingfisheries; testinginspectionresearchdevelopment of chemicals for life science
Publications
History of USPTO decisions and trademark events.
26 publications found
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/02/2024
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/14/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/06/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/21/2019
FIMP
FINAL DISPOSITION PROCESSED
10/21/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/02/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
07/02/2019
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
05/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2019
PUBO
PUBLISHED FOR OPPOSITION
04/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/19/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/19/2019
RFNP
REFUSAL PROCESSED BY IB
01/05/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/11/2018
RFRR
REFUSAL PROCESSED BY MPU
12/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/28/2018
CNRT
NON-FINAL ACTION WRITTEN
11/27/2018
DOCK
ASSIGNED TO EXAMINER
11/26/2018
MAFR
APPLICATION FILING RECEIPT MAILED
10/16/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/12/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
10/10/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
10/04/2018
Continuous trademark protection
Get notified about every new filing that threatens CYTOTUNE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.